These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15729595)

  • 21. Cancer therapy and polymorphisms of cytochromes P450.
    MacLeod SL; Nowell S; Massengill J; Jazieh A; McClure G; Plaxco J; Kadlubar FF; Lan NP
    Clin Chem Lab Med; 2000 Sep; 38(9):883-7. PubMed ID: 11097344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
    Ingelman-Sundberg M
    Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspective on the application of pharmacogenomics in the treatment of cancer.
    Wolf R
    Pharmacogenomics; 2009 Apr; 10(4):527-9. PubMed ID: 19374511
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic polymorphisms of cytochrome P450 enzymes and the effect on interindividual, pharmacokinetic variability in extensive metabolizers.
    Ma JD; Nafziger AN; Bertino JS
    J Clin Pharmacol; 2004 May; 44(5):447-56. PubMed ID: 15102864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K; Khattar SK; Saini KS
    Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].
    Yamazoe Y; Nagata K
    Nihon Rinsho; 2001 Aug; 59(8):1614-23. PubMed ID: 11519169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-based drug prescribing: clinical implications of the cytochrome P450 genes.
    Musana AK; Wilke RA
    WMJ; 2005 Aug; 104(6):61-6. PubMed ID: 16218319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacogenetics/pharmacogenomics in psychiatry].
    Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K
    Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
    Bertholee D; Maring JG; van Kuilenburg AB
    Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
    Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
    Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD; Lee YB
    Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
    Sauna ZE; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM
    Cancer Res; 2007 Oct; 67(20):9609-12. PubMed ID: 17942888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.